Is Zofran safe in pregnancy? The short answer, based on the best evidence available: the two largest studies — a Danish cohort of more than 600,000 births (Pasternak et al., JAMA, 2013) and a US study of 1.8 million pregnancies (Huybrechts et al., JAMA, 2018) — found no significant increase in overall birth defects with first-trimester ondansetron use. But Zofran, the brand name for ondansetron, is prescribed off-label in pregnancy — its FDA approval covers chemotherapy, radiation, and postoperative nausea, not morning sickness — and major guidelines still rank it behind first-line treatments like doxylamine plus vitamin B6. This article lays out exactly what the research shows, what the studies found trimester by trimester, the side effects, and the one cardiac caveat almost no pregnancy blog mentions — so you can have a genuinely informed conversation with your own provider.
What Is Zofran (Ondansetron)?
Ondansetron is a 5-HT3 serotonin receptor antagonist — a drug that blocks the serotonin signals in the gut and brain that trigger the vomiting reflex. The FDA approved it in 1991 for nausea and vomiting caused by cancer chemotherapy, later extending approval to radiation therapy and postoperative nausea and vomiting. "Zofran" is simply its best-known brand name; generic ondansetron is chemically identical.
In pregnancy, ondansetron is used entirely off-label. That word matters: it means no regulator has granted it a pregnancy-specific indication, so its use rests on observational evidence and professional guidelines rather than the randomized-trial package that usually supports an approval. It is nevertheless one of the most commonly prescribed anti-nausea drugs in US pregnancies, with use rising sharply through the 2000s — prescription records in the large Medicaid study discussed below show 4.9% of all pregnancies included a first-trimester ondansetron fill.
Is Zofran Safe in Pregnancy? What the Studies Show
No randomized trial has settled the question — Cochrane reviews of interventions for nausea and vomiting in early pregnancy note that ondansetron has rarely been tested in pregnancy randomized trials, which is exactly why researchers turned to enormous population cohorts. Here is what the two largest found.
The Danish Cohort: 600,000+ Births (Pasternak et al., JAMA, 2013)
Researchers at Denmark's Statens Serum Institut tracked 608,385 pregnancies between 2004 and 2011 through national prescription and birth registries, comparing roughly 1,970 women who filled an ondansetron prescription during pregnancy against the unexposed population. After adjusting for confounders, first-trimester exposure was not associated with a significantly increased risk of any major birth defect (adjusted prevalence odds ratio 1.12, with a 95% confidence interval of 0.69–1.82 — comfortably crossing 1.0, the line of no effect), nor with increased rates of spontaneous abortion, stillbirth, preterm delivery, or low birth weight.
The cohort's size is doing real work here. Major birth defects affect roughly 3 in every 100 births (CDC), so detecting — or ruling out — a modest increase in a rare outcome requires hundreds of thousands of pregnancies. Pasternak's team had exactly that scale, which is why this study shifted the conversation in 2013.
The US Medicaid Study: 1.8 Million Pregnancies (Huybrechts et al., JAMA, 2018)
The largest analysis to date examined 1,816,414 pregnancies covered by US Medicaid between 2000 and 2013, including 88,467 women (4.9%) exposed to ondansetron during the first trimester. The results: no significant increase in cardiac malformations (adjusted relative risk 0.99) or in overall malformations (adjusted relative risk 1.01) — both estimates sitting almost exactly at 1.0.
One finding did reach statistical significance: oral clefts showed an adjusted relative risk of 1.24, or roughly 3 additional cases per 10,000 exposed births (about 17.5 per 10,000 exposed versus 14.0 per 10,000 unexposed). That absolute framing is the part headlines usually drop — a 24% relative increase on a very rare outcome still means roughly 9,997 of every 10,000 exposed babies had no oral cleft. It is a signal worth knowing about, not a verdict.
What About the Earlier Warning Signals?
Before these mega-cohorts existed, smaller studies raised questions that understandably worried people. A Danish study (Andersen et al., Obstetrics & Gynecology, 2014) reported a possible association between ondansetron and heart defects, and some case-control analyses hinted at cleft palate signals. Those studies involved far fewer exposed pregnancies, so their risk estimates were imprecise — wide confidence intervals that leave the true effect unclear. The 2018 Medicaid analysis, with roughly 45 times more first-trimester exposures than the 2013 Danish cohort, is why most expert reviews now describe ondansetron as having no meaningful overall teratogenic signal, while honestly noting the small, uncertain cleft finding above.
How Does Zofran Compare to First-Line Nausea Treatments?
Ondansetron is not the first drug pregnancy guidelines recommend. ACOG's Practice Bulletin on nausea and vomiting of pregnancy (No. 189, published 2018 and reaffirmed in 2024) places the combination of doxylamine (10 mg) and pyridoxine — vitamin B6 (10 mg) — as the first-line pharmacologic treatment. That combination is the only FDA-approved drug specifically for nausea and vomiting of pregnancy, sold as the delayed-release tablet Diclegis (approved 2013) and the extended-release Bonjesta, dosed at up to 4 tablets per day.
The evidence ladder below ondansetron also includes ginger supplements and antihistamines for mild cases. Ondansetron enters the picture, per ACOG, when nausea and vomiting persist despite those first-line measures — a common real-world scenario, since nausea and vomiting of pregnancy affects an estimated 70–80% of pregnant women, typically starting around week 6, peaking between weeks 8 and 12 as hCG climbs, and easing for most by weeks 14 to 20. If you are mapping your own symptoms against that timeline, our week-by-week pregnancy guide shows what is typical at each stage, and the hCG Level Checker can show where your hormone levels sit for your week. Nausea also tends to arrive alongside other early-pregnancy symptoms — mild cramping is usually normal in early pregnancy too — which is why so many women end up researching several symptoms at once.
When Do Doctors Prescribe Zofran During Pregnancy?
Most ondansetron prescriptions cluster in the first trimester, when nausea and vomiting peak. Physicians typically reach for it when:
- First-line options (doxylamine + B6, ginger, dietary changes) have not controlled symptoms after a reasonable trial.
- Vomiting causes dehydration, ketonuria, or weight loss — weight loss exceeding 5% of pre-pregnancy body weight marks the line into hyperemesis gravidarum, a severe form of pregnancy vomiting affecting an estimated 0.3–3% of pregnancies, which can require IV fluids and sometimes hospitalization.
- A woman cannot keep oral first-line medications down at all, making a dissolvable ondansetron tablet (ODT) the practical option.
Prescribers generally aim for the lowest effective dose for the shortest needed duration — commonly 4 mg every 6 to 8 hours as prescribed, and only as your provider directs — and they reassess as nausea typically fades in the second trimester. As the worst of the sickness lifts around weeks 12 to 14, many women shift their attention to new milestones: most first feel their baby move between weeks 16 and 25, so the calendar starts feeling friendlier quickly.
One important distinction: severe abdominal pain with vomiting is not ordinary morning sickness. Pain that is sharp, one-sided, or accompanied by bleeding needs urgent evaluation, because ectopic pregnancy pain typically starts around 6 to 8 weeks — right in the window when nausea peaks. Never assume severe pain is "just" nausea.
Zofran Side Effects and Risks to Know About
In practice, ondansetron is generally well tolerated. The most commonly reported side effects are headache, constipation, fatigue, and dizziness — constipation being the complaint pregnant users mention most, since pregnancy itself already slows digestion. Staying hydrated and keeping fiber up helps, and if weeks of vomiting have made eating unpredictable, the Pregnancy Weight Gain Calculator can help you check whether your overall gain is still tracking within recommended ranges.
Then there is the caveat almost no pregnancy blog mentions: QT prolongation. Ondansetron can lengthen the heart's QT interval in susceptible people. In 2011–2012, the FDA revised the drug's label after data showed that a single intravenous dose above 16 mg can meaningfully prolong the QT interval, and the drug is contraindicated in patients with congenital long QT syndrome. The 4 mg oral doses used for pregnancy nausea are far below that threshold, and routine oral use has not been linked to cardiac events in the pregnancy cohorts — but it is why prescribers ask about personal or family history of heart rhythm problems before writing the prescription. If you have a known arrhythmia or take other QT-prolonging drugs, that history changes the conversation.
The Bottom Line on Zofran Safety in Pregnancy
Is Zofran safe in pregnancy? The evidence says: reassuring, with caveats. More than 2.4 million pregnancies across the two largest studies show no significant increase in overall birth defects, cardiac defects, or pregnancy loss with first-trimester ondansetron use. The one statistically significant signal — a small absolute increase in oral clefts of about 3 per 10,000 exposed births — is real but tiny, and expert guidelines (ACOG, 2018, reaffirmed 2024) still consider ondansetron an acceptable option when first-line treatments fail. It remains off-label, it is not the first choice, and the QT-interval caveat means cardiac history matters.
None of this is a prescription or a diagnosis — only your own provider, who knows your history, can weigh ondansetron against your symptoms. But you can now walk into that conversation knowing exactly what the numbers say.
If you are very early in pregnancy and your nausea started before you even confirmed it, the When to Take a Pregnancy Test Calculator can help you time testing around your cycle — and whatever the result, bring your symptom notes to your first prenatal visit.